Navigation Links
Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry
Date:3/21/2011

hibitors in Dermatology 33

Select Drugs/Therapeutics with Angiogenic Mode of Action

Approved by FDA for Dermatology 33

4. MARKET TRENDS 34

Cancer - The Key Target Indication for Research in Anti-

Angiogeneis Drugs 34

Avastin Continues to Record Robust Growth 34

New Markets Offer Higher Potential for Herceptin 34

Increased Use Drives Tarceva's Growth in Developed Markets 34

Angiogenesis Inhibitors Continue to Dominate RCC Drug Market 35

Votrient to Lead Renal Cell Carcinoma (RCC) Drug Market 35

Table 5: Leading Drugs in the Global Second Line Advanced

Renal Cell Carcinoma Market (2009): Percentage Breakdown by

Value Sales for Nexavar, Torisel, Afinitor, Avastin, and

Others (includes corresponding Graph/Chart) 36

Clinical Benefits of Votrient Over Sutent 36

Avastin's Approval for Breast Cancer Treatment Under Threat 37

5. ANGIOGENESIS REPERTOIRE 38

An In-depth Insight into Angiogenesis 38

Angiogenesis: At a Glance 38

Requisites for Angiogenesis 38

Endogenous Regulators of Angiogenesis 39

Angiogenic Process: Sequence of Events 39

Angiogenesis Process in Children 40

Angiogenesis Process in Adults 40

The Process of Angiogenesis in Thyroid Gland 40

6. ANGIOGENESIS INHIBITORS 41

Table 6: Global Market for Angiogenesis Inhibitors

(2009-2015): Geographic Regions Ranked by CAGR - USA, Europe,

and Rest of World (includes corresponding Graph/Chart) 41

Angiogenic Inhibitors: Basic Framework 41

Natural Inhibitors 41

Thrombospondin 41

Interferon 41

Cryptic Inhibitors 42

Other Natural Inhibitors 42

Natural Sources for Anti-Angiogenic Action 42

Potential Anti-Angiogenic Drugs of Natural Origin 42

Angiogenic Inhibitors: On the Verge of Attaining Superior

Clinical Efficacy 42

Endogenous vs Synthetic Agents 43<
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
2. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
3. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
4. Reportlinker Adds Proteomics: Technologies and Global Markets Report
5. Reportlinker Adds Nanomedicine Report
6. Reportlinker Adds Small Molecule Kinase Inhibitors Report
7. Reportlinker Adds Nanoporous Materials Report
8. Reportlinker Adds Membrane Bioreactors Report
9. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
10. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
11. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... 21, 2015 Tunnell Consulting, ... firm as senior statistician and Principal, a position to ... in the management and analysis of complex and large ... industries. , “We’re delighted to have Julia join the ... analytics,” said Dr. Philippe Cini, Group Vice President and ...
(Date:5/20/2015)... , May 20, 2015  Select Medical Corporation ... Federal Trade Commission granted early termination of the ... Act of 1976, as amended, applicable to the ... Corporation, a joint venture that Select has created ... As previously announced, MJ Acquisition Corporation has ...
(Date:5/20/2015)... -- Haemonetics Corporation (NYSE: HAE ) announced today that ... at The Jefferies 2015 Global Healthcare Conference in ... , 2015 at 8:30am Eastern time.  ... webcast at: http://wsw.com/webcast/jeff88/hae ... a global healthcare company dedicated to providing innovative blood ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2
... California Institute for Nursing & Health Care (CINHC) released ... pilot New Graduate Nurse Transition to Practice Programs (RN ... San Francisco, found that the programs are making a ... graduates and increasing their employment opportunities in hospitals and ...
... (NASDAQ: SQNM ), a life sciences company providing ... the Jefferies 2012 Global Healthcare Conference at the Grand Hyatt ... Harry F. Hixson, Jr., Ph.D., Chairman and CEO, will ... ET, to provide an overview of and update on the ...
... May 25, 2012 /PRNewswire-iReach/ – Nitor ... and a significant contributor to the advancement of the ... implementation to today,s production status, has been selected to ... suite to optimize patient care, safety and efficiency through ...
Cached Biology Technology:Study Shows Transition to Practice Programs Get Nurses Employed 2Nitor Group Demonstrates Direct Product Suite at Direct Implementation and Adoption Summit May 31-June 1 2
(Date:4/14/2015)... NEW YORK , April 14, 2015 /PRNewswire/ ... Fast IDentity Online (FIDO ® ) Alliance tm ... standards-based specifications. FIDO members commit to share technology ... authentication methods that are interoperable, more secure and ... specifications enable biometric identity verification that protects sensitive ...
(Date:4/13/2015)... -- higi, a leading cloud-based consumer engagement platform that provides ... their communities around health and wellness, announced today the ... ... convenient vehicle to receive validated health information from consumers. ... API will allow higi,s trusted partners, on a user ...
(Date:4/8/2015)... CHARLOTTE, N.C. , April 8, 2015 /PRNewswire/ ... technology solutions and services, and Morpho, a leading ... in partnership to produce the market,s most advanced ... Infinisource,s iSolved NXG time clock is setting ... attendance and labor data for the small and ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3
... populating the growing brain, neural stem cells must strike a ... the cells multiply to provide plenty of starting materials ... If the stem cells proliferate too much, they could ... proliferate too little, there may not be enough cells to ...
... / b3c newswire / - KINAXO Biotechnologies GmbH ... service portfolio. KinAffinity provides invaluable information about a ... of interest. It simultaneously determines affinities for native ... overcomes the limitations of traditional biochemical assays that ...
... of researchers from the University of Maryland Center for ... study to forecast the effects of environmental change on ... by a $620,000 grant from the National Science Foundation, ... Preserve near Alexandria, Virginia. "Freshwater marshes are integral ...
Cached Biology News:UNC study pinpoints gene controlling number of brain cells 2KINAXO launches KinAffinity services for efficient profiling of kinase inhibitors in cells or tissue 2
4',6-Diamidino-2-phenylindole, dihydrochloride (DAPI)...
... The PROTEAN II xi multi-cell is for 2-D ... efficient cooling capabilities. The PROTEAN II xi multi-cell ... comb, type of glass plates, and cooling system. ... converted to the PROTEAN II XL multi-cell for ...
... been developed with the drug discovery process ... sensitivity and performance, Safire is the ideal ... development and high throughput screening. Safire is ... that offers a range of high speed ...
... xi cell, 16 cm, is used for vertical ... in agarose gels. The cell is supplied without ... cooling core with gaskets, lower buffer chamber, lid ... sandwich clamps, upper buffer dam, casting stand with ...
Biology Products: